Outcomes of bronchial artery embolization for the management of hemoptysis

Hemoptysis is an alarming symptom that requires immediate investigation and management. Bronchial artery embolization (BAE) is a minimally invasive procedure that has become the treatment of choice of recurrent and massive hemoptysis. To assess the efficacy and safety of BAE for management of recu...

Full description

Saved in:

Bibliographic Details
Published in:	La Tunisie medicale Vol. 99; no. 2; pp. 264 - 268
Main Authors:	Abid, Narjes, Loukil, Manel, Mokni, Amani, Badri, Imen, Bouzaidi, Khaled, Ghrairi, Hedia
Format:	Journal Article
Language:	English
Published:	Tunisia Societe Tunisienne Des Sciences Medicales 01-02-2021
Subjects:	Bronchial Arteries Embolization, Therapeutic Hemoptysis - diagnosis Hemoptysis - etiology Hemoptysis - therapy Humans Neoplasm Recurrence, Local Recurrence Retrospective Studies Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Hemoptysis is an alarming symptom that requires immediate investigation and management. Bronchial artery embolization (BAE) is a minimally invasive procedure that has become the treatment of choice of recurrent and massive hemoptysis. To assess the efficacy and safety of BAE for management of recurrent and/or massive hemoptysis. A retrospective analysis was carried out of the medical records of 46 patients who were hospitalized in our department of pneumology in Mohamed Taher Maamouri hospital for hemoptysis and who underwent bronchial arteriography (BA) for the purpose of transarterial embolization. The most frequent causes of hemoptysis included idiopathic bronchiectasis (32.6%), pulmonary tumors (26%) and tuberculosis (8.6%) Embolization was successfully performed in 97.5% of cases. Immediate cessation of haemoptysis was achieved in 95%. Recurrence of haemoptysis was noted in 12% of cases. No major complication involving the vital or the functional prognosis, related to BAE was noted. Conclusions: Our study confirms the safety and the efficacy of the BAE for management of massive and/or recurrent hemoptysis.
ISSN:	0041-4131 2724-7031